XKRX:293780 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
5300.00
(-2.93%)
May 24
Business Description
Aptabio Therapeutics Inc
ISIN : KR7293780003
Share Class Description:
XKRX:293780: Ordinary SharesCompare
Compare
Traded in other countries / regions
293780.Korea IPO Date
2019-06-12Description
Aptabio Therapeutics Inc is a South Korean pharmaceutical company involved in discovery and development of selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The product portfolio of the company include Lipofector-Q, Plusfector, Lipofector-EXT, Lipofector-2000, Lipofector-EZ and Lipofector-pMAX.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | -1.4 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.48 | |||||
| Beneish M-Score | 13.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.7 | |||||
| 3-Year EBITDA Growth Rate | -51.1 | |||||
| 3-Year EPS without NRI Growth Rate | -39.9 | |||||
| 3-Year FCF Growth Rate | -33.2 | |||||
| 3-Year Book Growth Rate | -5.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.61 | |||||
| 9-Day RSI | 25.48 | |||||
| 14-Day RSI | 32.31 | |||||
| 6-1 Month Momentum % | -27.94 | |||||
| 12-1 Month Momentum % | -47.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 51.37 | |||||
| Quick Ratio | 51.37 | |||||
| Days Sales Outstanding | 1.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | -8.54 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 14.21 | |||||
| Operating Margin % | -1348.95 | |||||
| Net Margin % | -1227.68 | |||||
| FCF Margin % | -1514.69 | |||||
| ROE % | -20.89 | |||||
| ROA % | -15 | |||||
| ROIC % | -27.45 | |||||
| ROC (Joel Greenblatt) % | -65.42 | |||||
| ROCE % | -13.51 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 127.98 | |||||
| PB Ratio | 2.05 | |||||
| Price-to-Tangible-Book | 2.05 | |||||
| EV-to-EBIT | -7.81 | |||||
| EV-to-EBITDA | -8.03 | |||||
| EV-to-Revenue | 84.7 | |||||
| EV-to-FCF | -5.59 | |||||
| Price-to-Net-Current-Asset-Value | 5.18 | |||||
| Earnings Yield (Greenblatt) % | -12.8 | |||||
| FCF Yield % | -12.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aptabio Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 941.613 | ||
| EPS (TTM) (â‚©) | -509.889 | ||
| Beta | 1.67 | ||
| Volatility % | 63.64 | ||
| 14-Day RSI | 32.31 | ||
| 14-Day ATR (â‚©) | 285.667636 | ||
| 20-Day SMA (â‚©) | 5841 | ||
| 12-1 Month Momentum % | -47.03 | ||
| 52-Week Range (â‚©) | 4935 - 13330 | ||
| Shares Outstanding (Mil) | 22.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aptabio Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aptabio Therapeutics Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aptabio Therapeutics Inc Frequently Asked Questions
What is Aptabio Therapeutics Inc(XKRX:293780)'s stock price today?
The current price of XKRX:293780 is â‚©5300.00. The 52 week high of XKRX:293780 is â‚©13330.00 and 52 week low is â‚©4935.00.
When is next earnings date of Aptabio Therapeutics Inc(XKRX:293780)?
The next earnings date of Aptabio Therapeutics Inc(XKRX:293780) is .
Does Aptabio Therapeutics Inc(XKRX:293780) pay dividends? If so, how much?
Aptabio Therapeutics Inc(XKRX:293780) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers